Capivasertib (C) plus fulvestrant (F) for patients (pts) with aromatase inhibitor (AI)-resistant HR+/HER2e advanced breast cancer (ABC): Phase III CAPItello-291 trial Chinese cohort

X. Hu,Q. Zhang, T. Sun,H. Xiong, W. Li,Y. Teng,Y-S. Lu,L-M. Tseng, M. Yan, H. Li, D. Pang,S. C. Chen, W. Chen,O. Jiang, J. Wang, X. Wu, E. Fan, L. Jiang, X. Zeng,N. Turner

ANNALS OF ONCOLOGY(2023)

引用 0|浏览27
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要